Asia Pacific Jan 15, 2023
China’s 60,000 COVID-19 death toll spurs calls for more data
China COVID-19 surge since December has spurred concern about variants; WHO chief stresses importance of transparency.
China’s 60,000 COVID-19 death toll spurs calls for more data
China COVID-19 surge since December has spurred concern about variants; WHO chief stresses importance of transparency.
Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine
An approval would give Japan a homegrown mRNA vaccine — a vaccine type that has played a dominant role in the country's COVID-19 inoculation drive to this point.
Health concerns, not pride, should guide COVID-19 travel policy
Apparently China can shut its borders to reduce the risk of COVID-19 infections, but Beijing doesn't think other countries should do the same.
Why the future of technology is so hard to predict
It’s 2023, yet we’re not all riding Segways, having sex with robots or cloning humans. What gives?
Don't write off the retooled COVID-19 boosters
Two new studies claim the bivalent omicron shot is no better than the original vaccine. But there are important caveats.
Health ministry suggests restricting bulk drug purchases amid hoarding fears
The message follows reports of Chinese people in the country buying medicine in bulk and mailing it to friends and families back home.
Eisai shares jump after FDA approves Alzheimer’s drug lecanemab
The drug, to be sold under the brand name Leqembi, was approved by the Food and Drug Administration under an accelerated pathway.
China’s COVID surge threatens villages as Lunar New Year approaches
China is bracing for an onslaught of infections in its fragile countryside as millions of people crowd onto trains and buses to return to their rural homes for the Lunar New Year holiday.
Beijing is in talks with the drugmaker to secure a license that will allow domestic firms to manufacture and distribute a generic version of its Paxlovid antiviral drug.
No, vaccines aren’t making new COVID-19 variants worse
The omicron sequel XBB.1.5 is driving a new wave of COVID-19 infections — and misinformation.
Cancer vaccine hunt finally makes progress
A small study shows promise in deploying mRNA technology against melanoma — but fighting tumors is vastly more complex than tackling COVID-19.
China's COVID wave sparks scramble for vital drugs across Asia
Beijing’s decision to abruptly remove most pandemic restrictions with little preparation is driving an unprecedented number of cases, leaving hospitals and funeral homes overwhelmed.